Anika Therapeutics (ANIK) Stock: Buy, Sell, or Hold?
ANIK - Anika Therapeutics Inc
$20.81
-0.22 (-1.05%)
▼
5d:
-0.24%
30d:
-2.12%
90d:
+44.31%
HOLD
MODERATE Confidence
Analysis Updated: Sep 18, 2026 12:00 AM ET
Earnings: Nov 04, 2026
Get Alerted When ANIK Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ANIK shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: ANIK shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$20.53
Based on -2.7% avg growth
INTRINSIC VALUE TODAY
$12.75
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ANIK is currently trading at $20.81, which is considered oversold relative to its 30-day fair value range of $20.88 to $21.46. From a valuation perspective, the stock is trading at a discount (Forward PE: 21.9) compared to its historical average (33.5). Remarkably, the market is currently pricing in an annual earnings decline of 13.2% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, ANIK is in a strong uptrend. Immediate support is located at $20.16, while resistance sits at $21.50.
Market Sentiment: The stock scores a mixed 48/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ANIK is in a strong uptrend. Immediate support is located at $20.16, while resistance sits at $21.50.
Market Sentiment: The stock scores a mixed 48/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$20.88 -
$21.46
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.6%
Protect Your Profits
Holding ANIK? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (48/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($21.00)
- NEUTRAL: Bottoming setup forming (48/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$20.88 -
$21.46
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$1.18
(5.7%)
Support & Resistance Levels
Support Level
$20.16
Resistance Level
$21.50
Current Trend
Strong Uptrend
Technical data as of
Sep 18, 2026
Fundamental Context
Forward P/E (Next Year Est.)
21.91
Wall Street Target
$21.00
(+0.9%)
Revenue Growth (YoY)
15.6%
Earnings Growth (YoY)
-50.5%
Profit Margin
-3.1%
Valuation Discount vs History
-13.2% cheaper
PE vs Historical
21.9 vs 33.5
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-13.2%
(market-implied from PE analysis)
1-Year Target
$18.73
(-10%)
2-Year Target
$16.86
(-19%)
3-Year Target
$15.17
(-27%)
3-Yr Target (if PE normalizes)
(PE: 22→34)
$23.20
(+12%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.9, Growth: -9.5%)
$15.41
(+-26%)
Base:
(SPY PE: 20.2, Growth: -9.5%)
$14.21
(-32%)
Bear:
(PE: 17.2, Growth: -9.5%)
$12.08
(-42%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 21.9 to 33.5
Stabilization Target:
$31.82
(+52.9%)
PE Expansion Potential:
+52.9%
Share & Embed Analysis
Last updated: September 21, 2026 2:59 AM ET
Data refreshes hourly during market hours. Next update: 3:59 AM
Data refreshes hourly during market hours. Next update: 3:59 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ANIK showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$210 | 36 SELL |
|
INDV
Indivior PLC Ordinary Sh… |
STRONG BUY
7 analysts |
$49 | 77 BUY |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 57 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$108 | 46 HOLD |
|
LQDA
Liquidia Technologies Inc |
STRONG BUY
10 analysts |
$108 | 62 BUY |
Advanced ANIK Option Strategies
Professional options setups generated by AI based on today's ANIK price and gamma walls.
